FDA plans meeting to discuss safety data on breast implants
U.S. health officials said they'll convene a public meeting of medical advisers next year to discuss new science on breast implant safety. That includes an independent analysis to be published Saturday that suggests certain rare health problems might be more common with silicone gel implants.
The Food and Drug Administration said it would hold the meeting even as its officials and several independent experts disputed the new work. Study leaders concede it has limitations and cannot prove that implants cause the health problems.
The research involves nearly 100,000 women and is the largest analysis of silicone implants since 2006, when they were allowed back on the U.S. market after a gap due to safety concerns.
Annals of Surgery is publishing the study.